-
- Klara Sjögren
- Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
-
- Cecilia Engdahl
- Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
-
- Petra Henning
- Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
-
- Ulf H Lerner
- Department of Molecular Periodontology, Umeå University, Umeå, Sweden
-
- Valentina Tremaroli
- Center for Cardiovascular and Metabolic Research/Wallenberg Laboratory, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
-
- Marie K Lagerquist
- Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
-
- Fredrik Bäckhed
- Center for Cardiovascular and Metabolic Research/Wallenberg Laboratory, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
-
- Claes Ohlsson
- Centre for Bone and Arthritis Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden
Description
<jats:title>Abstract</jats:title> <jats:p>The gut microbiota modulates host metabolism and development of immune status. Here we show that the gut microbiota is also a major regulator of bone mass in mice. Germ-free (GF) mice exhibit increased bone mass associated with reduced number of osteoclasts per bone surface compared with conventionally raised (CONV-R) mice. Colonization of GF mice with a normal gut microbiota normalizes bone mass. Furthermore, GF mice have decreased frequency of CD4+ T cells and CD11b+/GR 1 osteoclast precursor cells in bone marrow, which could be normalized by colonization. GF mice exhibited reduced expression of inflammatory cytokines in bone and bone marrow compared with CONV-R mice. In summary, the gut microbiota regulates bone mass in mice, and we provide evidence for a mechanism involving altered immune status in bone and thereby affected osteoclast-mediated bone resorption. Further studies are required to evaluate the gut microbiota as a novel therapeutic target for osteoporosis. © 2012 American Society for Bone and Mineral Research.</jats:p>
Journal
-
- Journal of Bone and Mineral Research
-
Journal of Bone and Mineral Research 27 (6), 1357-1367, 2012-03-09
Oxford University Press (OUP)
- Tweet
Details 詳細情報について
-
- CRID
- 1363388844327145856
-
- ISSN
- 15234681
- 08840431
-
- Data Source
-
- Crossref